Clinical Trial

National Plaque Registry and Database

Study acronym: OPeRA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The ultimate goal of this project is to develop a risk score to identify patients with vulnerable coronary atherosclerotic plaques, who are prone to suffer acute coronary syndrome. Early identification of vulnerable plaques may have an enormous impact on public health through primary and secondary prevention of acute myocardial infarction. Investigators hypothesize that a risk score that incorporates non-invasive coronary CT imaging (calcium score and/or coronary CTA) in combination with clinical characteristics (classical risk prediction models) will improve the identification of patients who are at highest risk to suffer myocardial infarction or sudden cardiac death. The overall goal of the OPeRA project is to develop, implement and validate a novel risk assessment tool based on image markers and clinical characteristics to identify patients who are at increased risk to suffer myocardial infarction or sudden cardiac death.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2015-10-15; most recent amendment 2017-04-24.
Trial Details
NCT Number NCT02578355
Lead Sponsor Semmelweis University Heart and Vascular Center
Collaborators: Hungarian Academy of Sciences
Conditions Atherosclerosis, Coronary Artery Disease, Cardiovascular Disease
Enrollment 20,000 participants
Start Date 2016-09
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2017-04-25